Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver Disease-Reference-Cited by-同舟云学术

Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver Disease

Published:2024 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Akuta Norio¹,Kawamura Yusuke¹,Sezaki Hitomi¹,Nakamichi Kenichi²,Saegusa Eiji²,Ogura Hidetoshi²,Kato Masaki²,Doi Etsuko³,Inoue Naoko³,Hosaka Tetsuya¹,Saitoh Satoshi¹,Kobayashi Mariko⁴,Fujiyama Shunichiro¹,Arase Yasuji¹,Ikeda Kenji¹,Suzuki Yoshiyuki¹,Kumada Hiromitsu¹,Suzuki Fumitaka¹

Affiliation:

1. Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Japan

2. Department of Rehabilitation, Toranomon Hospital, Japan

3. Department of Nutrition, Toranomon Hospital, Japan

4. Liver Research Laboratory, Toranomon Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3650-24/_pdf

Reference15 articles.

1. 1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.

2. 2. Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 32: 3-13, 2012.

3. 3. Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. Hepatol Res 51: 1013-1025, 2021.

4. 4. Akuta N, Kawamura Y, Arase Y, et al. PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD. BMC Gastroenterol 21: 434, 2021.

5. 5. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. ASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77: 1797-835, 2023.